Skip to main content
Fig. 7 | BMC Cancer

Fig. 7

From: Salinomycin inhibits metastatic colorectal cancer growth and interferes with Wnt/β-catenin signaling in CD133+ human colorectal cancer cells

Fig. 7

Salinomycin down-regulates the mRNA expression of Fibronectin and Lgr5 in human CD133+/CD133- colorectal cancer cells. The mRNA expression levels of Fibronectin (a + b) and Lr5 (c + d) in CD133+/CD133- SW620 and CD133+/CD133- HT29 cells were measured by quantitative PCR after treatment with1 μM 5-FU or increasing concentrations of Salinomycin (1, 2, 5 and 10 μM). * p < 0.05, ** p < 0.001 compared to control

Back to article page